Wendy Picking
  • Professor
School of Pharmacy - Pharmaceutical Chemistry
785-864-5963
Office
Multidisciplinary Research Building, Room 160
University of Kansas
2030 Becker Drive
Lawrence, KS 66047

Education

Ph.D., University of Kansas, Lawrence, KS

Research Overview

Many Gram-negative bacterial pathogens possess a type III secretion system that is responsible for injecting proteins into a host cell to subvert normal host cell processes for the benefit of the pathogen – often to promote invasion of the cell. The injection nanomachine is called the type III secretion apparatus (T3SA) and it resembles a syringe embedded in the bacterial membranes with an external needle and needle tip complex that senses target cell contact. The proteins make up the T3SA are highly conserved among closely related bacteria making them the ideal serotype-independent candidates for broadly protective vaccines. We have developed a subunit vaccine by fusing the Shigella T3SA proteins. We have shown it is protective in mice and non-human primates using a variety of routes and adjuvants. Currently, we are using this same platform to develop a broadly protective vaccine against Salmonella.

Research Interests

  • Vaccine Development - especially for children of low income countries
  • Enteric bacterial pathogenesis
  • Type III Secretion
  • Salmonella
  • Protein Production and Characterization

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today
Research

Our research projects ranging from traditional pharmaceutics to biotechnology. 

Learn more here.

Facebook